AB-CHMINACA

Description

1. Product Overview
AB-CHMINACA (also searched as AB CHMINACA) is a high-potency indazole carboxamide synthetic cannabinoid belonging to the category of novel psychoactive substances (NPS). Its high affinity for cannabinoid receptors makes it a critical compound for modern forensic research and toxicology. As a more recent and potent analogue, it is essential for laboratories to have a pure reference material to accurately detect its presence in casework and biological samples, thereby contributing to public health and safety.

Our AB-CHMINACA is synthesized and purified to the highest standards, ensuring exceptional chemical integrity for sensitive analytical techniques. Each batch is accompanied by comprehensive analytical data, including Gas Chromatography-Mass Spectrometry (GC-MS) and Nuclear Magnetic Resonance (NMR) spectroscopy reports, guaranteeing its identity and high purity for accurate and reliable research outcomes.

2. Key Features and Specifications

• Compound Name: AB-CHMINACA (N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)
• Chemical Purity: ≥ 98% (Verified by GC-MS & NMR)
• Format: Crystalline solid or powder
• Application: For use as an Analytical Reference Standard
• Storage: Must be stored in a cool, dry environment away from light to maintain stability.

3. Intended Application and Use
This reference material is indispensable for:

• Forensic Research: Serving as a critical calibration standard for the chemical analysis and identification of AB-CHMINACA in unknown powder samples or herbal blends, enabling accurate law enforcement and legal reporting.
• Clinical Toxicology: Assisting toxicology labs in developing and validating highly sensitive screening methods to detect and confirm the presence of AB-CHMINACA and its metabolites in biological specimens, which is crucial for harm reduction and overdose investigation.
• Pharmacological Study: Used in vitro by researchers to study the powerful binding affinity and functional activity of next-generation synthetic cannabinoids on CB1 and CB2 receptors.
• Method Development: Allowing laboratories to calibrate equipment like HPLC and GC-MS, ensuring the accuracy and precision of their analytical workflows for potent novel psychoactive substances (NPS).

4. Important Legal Notice & Disclaimer
AB-CHMINACA is an extremely potent synthetic compound classified as a synthetic cannabinoid receptor agonist. This product is sold exclusively as a controlled reference material for legitimate research applications by qualified professionals in certified laboratories. It is NOT intended for human or animal consumption, diagnostic use, or any other form of use. Handling requires a sophisticated understanding of chemistry and strict safety protocols. It is significantly more potent than older compounds like JWH-018.

5. Safety and Handling Warning
AB-CHMINACA is an extremely potent substance with severe potential health risks. It must be handled with extreme caution in a controlled laboratory setting. Researchers are required to use appropriate personal protective equipment (PPE), including gloves, lab coats, and safety glasses. All procedures should be conducted in a fume hood to avoid inhalation or accidental exposure. This product is for research purposes only by qualified individuals.